Disc Medicine Inc Ordinary Shares IRON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
Trading Information
- Previous Close Price
- $73.47
- Day Range
- $73.51–76.19
- 52-Week Range
- $40.10–99.20
- Bid/Ask
- $75.45 / $75.75
- Shares Outstanding
- 38.20M
- Market Cap
- $2.89B
- Volume/Avg
- 80,745 / 568,664
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 155
- Website
- https://www.discmedicine.com
Valuation
|
Metric
|
IRON
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.08 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IRON
|
|---|---|
Quick Ratio | 23.45 |
Current Ratio | 24.00 |
Interest Coverage | −74.71 |
Quick Ratio
IRON
Profitability
|
Metric
|
IRON
|
|---|---|
Return on Assets (Normalized) | −29.49% |
Return on Equity (Normalized) | −32.06% |
Return on Invested Capital (Normalized) | −33.40% |
Return on Assets
IRON
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|g<L@Wd# | LOCK|^f<d | $121B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|QsDdLP | LOCK|D$>? | $70B | |||
| argenx SE ADR
ARGX
| LOCK|J@%@@x | LOCK|Fd | $54B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|$&^cVQ^ | LOCK|W??wD | $37B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|C&YW^L | LOCK|K@ | $37B | |||
| Moderna Inc
MRNA
| LOCK|jCQbcq | LOCK|Nmk | $27B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|!M?vKNT | LOCK|^%W@ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|Vz#nKc | LOCK|@! | $23B | |||
| Incyte Corp
INCY
| LOCK|SXcRBL | LOCK|!@% | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|#>&rM#? | LOCK|Y$& | $16B |
United States